← Back to Search

Immediate Antibiotics for Cystic Fibrosis (STOP-PEDS Trial)

N/A

Waitlist Available

Led By Donald B. Sanders, MD

Research Sponsored by University of Washington, the Collaborative Health Studies Coordinating Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 18 months

Awards & highlights

STOP-PEDS Trial Summary

This trial is testing whether it is better to give immediate antibiotics to children with CF who have a pulmonary exacerbation, or to tailor the therapy based on the individual.

Eligible Conditions

Cystic Fibrosis

STOP-PEDS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Delayed antibiotics

Secondary outcome measures

Consent

Day 28 Follow-up

Participant Exacerbations

+3 more

STOP-PEDS Trial Design

2Treatment groups

Experimental Treatment

Group I: Tailored TherapyExperimental Treatment1 Intervention

increased airway clearance alone, with addition of antibiotics for worsening symptoms or failure to improve

Group II: Immediate AntibioticsExperimental Treatment1 Intervention

increased airway clearance plus early initiation of oral antibiotics

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Washington, the Collaborative Health Studies Coordinating CenterLead Sponsor

5 Previous Clinical Trials

9,504 Total Patients Enrolled

3 Trials studying Cystic Fibrosis

616 Patients Enrolled for Cystic Fibrosis

Cystic Fibrosis FoundationOTHER

189 Previous Clinical Trials

37,089 Total Patients Enrolled

182 Trials studying Cystic Fibrosis

34,152 Patients Enrolled for Cystic Fibrosis

Donald B. Sanders, MDPrincipal InvestigatorRiley Children's Hospital, Indianapolis, IN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there numerous sites operating this research project within the state's borders?

"Currently, 10 locations are participating in this medical study. Examples of these sites include Atlanta, Grand Rapids and Pittsburgh. To limit travel time for the participant, it is recommended to select a trial site that is nearby."

Answered by AI

Is this study available to geriatric individuals?

"The trial has predetermined that applicants must range from 6 to 18 years of age. There are 86 trials for minors and 374 open studies available for the elderly demographic."

Answered by AI

To whom is enrollment in this research initiative open?

"To be considered for this cystic fibrosis study, volunteers must lie within the age range of 6 and 18 years old. An estimated 121 individuals will be enrolled in total."

Answered by AI

Is this research initiative still recruiting participants?

"The clinical trial in question, posted on November 10th 2020 and last updated December 22nd 2021, is no longer seeking participants. However, at the current moment there are 413 other trials actively enrolling patients for various medical interventions."

Answered by AI

Recent research and studies

European Respiratory JournalJournal

Pulmonary Function, Inflammation, Exercise Capacity and Quality of Life in Cystic Fibrosis

Bradley, J., O. McAlister, and S. Elborn. 2001. “Pulmonary Function, Inflammation, Exercise Capacity and Quality of Life in Cystic Fibrosis”. European Respiratory Journal. European Respiratory Society (ERS). doi:10.1183/09031936.01.17407120.

clinicaltrials.govStudy

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

2020. "Streamlined Treatment of Pulmonary Exacerbations in Pediatrics". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04608019.